Diana Ernst, RPh

The trial met its primary endpoint with a significantly larger proportion of delgocitnib-treated patients achieving treatment success.

The AAP has released a new list of 5 tests and procedures commonly ordered in pediatric emergency medicine that physicians and patients should question.

The INTEGUMENT-1 study met the primary endpoint and all secondary endpoints.

Xylazine is centrally-acting alpha2-adrengeric agonist that was originally approved in 1972 as a sedative and analgesic for use in veterinary medicine.

Semaglutide is a glucagon-like peptide-1 receptor agonist.

Prompt initiation of systemic antiviral therapy in addition to topical trifluridine should be considered in patients with ocular manifestations of monkeypox.

The COSMOS-Mind study included 2262 participants and evaluated the effects of cocoa extract and multivitamin-mineral supplementation on cognitive function.

Ritlecitinib is the first in a new class of oral highly selective kinase inhibitors.

The approval was based on data from 2 identical phase 3 studies, PSOARING 1 and PSOARING 2.

Laboratory analyses revealed certain Artri and Ortiga products contain undeclared drug ingredients.